Home | Publications | Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Published on: 3 December, 2020

Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine. 2020 Dec 3;17(12):e1003432.

doi.org/10.1371/journal.pmed.1003432

Link to Publication

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study

Published on: 3 December, 2020

Related Themes

Musculoskeletal

Related Team Members

Professor Ann Morgan

Associate Director of Translational Research